![]() |
市場調查報告書
商品編碼
1896205
全球免疫力增強食品、飲料和補充劑市場預測至2032年:按產品類型、形式、分銷管道、性質、應用和地區分類的分析Immunity-Boosting Foods, Beverages & Supplements Market Forecasts to 2032 - Global Analysis By Product Type (Foods, Beverages, Supplements, and Other Product Types), Form, Distribution Channel, Nature, Application and By Geography |
||||||
根據 Stratistics MRC 的一項研究,全球增強免疫力的食品、飲料和補充劑市場預計到 2025 年價值 258.4 億美元,到 2032 年達到 434.4 億美元,在預測期內以 7.7% 的複合年成長率成長。
增強免疫力的食物、飲料和營養補充品旨在強化人體自身抵抗感染疾病和疾病的能力。這些包括富含維生素和礦物質的水果、蔬菜、草藥,以及添加了抗氧化劑和益生菌的機能飲料。維生素C、維生素D、鋅和植物萃取物等營養補充劑在維持免疫健康方面發揮重要作用。將這些產品融入日常生活中,可以增強免疫功能,促進整體健康,並有助於預防疾病,從而使其成為預防保健和健康策略的重要組成部分。
文明病及感染疾病呈上升趨勢
久坐的生活方式、不良的飲食習慣和日益成長的壓力正在削弱各年齡層的免疫力。消費者越來越傾向於積極主動地進行預防性保健,而非被動地接受治療。富含維生素、礦物質、益生菌和抗氧化劑的機能性食品正被廣泛接受。數位媒體和健康宣傳活動提高了人們對免疫健康的認知,也影響他們的購買行為。人口老化和免疫力缺乏功能低下人群的增加也推動了市場需求的持續成長。隨著免疫力成為健康的核心要素,製造商正在拓展產品系列,以滿足多樣化的健康需求。
缺乏標準化的臨床證據
許多產品依賴傳統知識和初步研究,而非大規模的同儕審查臨床試驗。成分品質、劑量和配方方面的差異使得產品的有效性難以持續檢驗。監管機構對健康聲明的審查日益嚴格,給生產商帶來了合規方面的挑戰。消費者對過度宣傳的懷疑也限制了消費者的信任。小規模品牌難以投入大量資源進行大規模的研究和檢驗。這些因素共同導致免疫增強類產品推廣速度緩慢,並限制了其長期信譽。
對個人化營養和標靶免疫支持的需求日益成長
消費者越來越傾向於根據自身年齡、生活方式、飲食習慣和特定健康狀況來尋求針對性的免疫解決方案。營養基因組學和微生物組研究的進步使得定製配方成為可能。數位健康平台和行動應用程式正在推動個人化營養補充劑推薦。品牌正在利用數據分析和人工智慧驅動的工具來提升消費者參與度和產品相關性。個人化訂閱營養模式正在興起,尤其是在都市區消費者中。這種向個人化免疫支援解決方案的轉變,正在為那些推動創新的公司開闢新的成長途徑。
現有品牌的激烈競爭
大型企業受益於強大的品牌知名度、廣泛的分銷網路和雄厚的行銷預算。新參與企業在競爭激烈的市場中難以實現產品差異化。價格競爭和頻繁的產品推出加劇了利潤率的壓力。現有品牌往往在線上和線下零售通路佔據主導地位。零售商的自有品牌產品進一步加劇了動態。
新冠疫情的影響
新冠感染疾病顯著改變了增強免疫力的食品、飲料和保健品市場。人們對免疫健康的日益重視,導致維生素、草藥補充劑和機能飲料的需求激增。供應鏈中斷最初影響了原料採購和生產能力。然而,疫情加速了數位化分銷管道和直銷模式的普及。監管機構暫時放寬了限制,以確保尖峰時段的產品供應。疫情過後,免疫產品已從短期預防用途轉變為日常健康必需品。
預計在預測期內,膳食補充劑細分市場將佔據最大的市場佔有率。
由於其便捷性、濃縮營養和廣泛的供應管道,預計在預測期內,膳食補充劑細分市場將佔據最大的市場佔有率。膠囊、錠劑、粉末和軟糖等劑型服用方便,且便於精確控制劑量。消費者對維生素、礦物質、益生菌和草藥萃取物的高度認知推動了強勁的需求。膳食補充劑被各個年齡層的人廣泛用於預防和治療免疫支持。頻繁的產品創新和潔淨標示配方提升了該細分市場的吸引力。在藥局、超級市場和線上平台的廣泛銷售也提高了產品的供應量。
預計在預測期內,線上零售領域將呈現最高的複合年成長率。
在數位化和便利性的推動下,預計線上零售領域在預測期內將保持最高的成長率。電商平台提供種類繁多的免疫力產品,並附有透明的成分資訊和使用者評估。訂閱模式和個人化推薦有助於提高客戶維繫。極具競爭力的價格和宅配服務吸引了都市區消費者和精通科技的消費者。注重健康的線上市場的興起正在擴大產品的覆蓋範圍。品牌正在利用社群媒體和網紅行銷來促進線上銷售。
由於消費者健康意識強、購買力旺盛,預計北美地區在預測期內將佔據最大的市場佔有率。消費者積極投資於預防性醫療保健和膳食補充劑。該地區擁有成熟的膳食補充劑產業,並具備強大的研發能力。有利的法規結構有利於免疫產品的快速商業化。文明病的高發生率進一步推動了市場需求。主要國際品牌的入駐也增強了市場滲透率。
由於快速的都市化和可支配收入的成長,預計亞太地區在預測期內將實現最高的複合年成長率。不斷壯大的中產階級越來越重視健康和保健。阿育吠陀和中草藥等傳統醫學體係正在影響消費者的行為,旨在增強免疫力。疫情後人們對預防性醫療保健意識提升正在加速需求成長。電子商務平台的擴張正在改善全部區域的產品供應。各國政府正在推廣營養和健康計劃,以改善公眾健康。
According to Stratistics MRC, the Global Immunity-Boosting Foods, Beverages & Supplements Market is accounted for $25.84 billion in 2025 and is expected to reach $43.44 billion by 2032 growing at a CAGR of 7.7% during the forecast period. Immunity-enhancing foods, drinks, and dietary supplements aim to fortify the body's natural defenses against infections and diseases. They encompass vitamin- and mineral-rich fruits, vegetables, herbs, and fortified functional beverages containing antioxidants and probiotics. Nutritional supplements such as vitamin C, vitamin D, zinc, and plant-based extracts play a crucial role in supporting immune health. Incorporating these products into daily routines can bolster immune function, promote overall well-being, and help prevent illnesses, positioning them as key elements in preventive healthcare and wellness strategies.
Increasing prevalence of lifestyle diseases and infections
Sedentary lifestyles, poor dietary habits, and rising stress levels have weakened immune resilience across populations. Consumers are becoming more proactive about preventive healthcare rather than reactive treatment. Functional foods fortified with vitamins, minerals, probiotics, and antioxidants are gaining widespread acceptance. Growing awareness about immune health through digital media and healthcare campaigns is influencing purchasing behavior. Aging populations and immunocompromised individuals further contribute to sustained market demand. As immunity becomes a core wellness priority, manufacturers are expanding product portfolios to address diverse health needs.
Lack of standardized clinical evidence
Many products rely on traditional knowledge or preliminary studies rather than large-scale, peer-reviewed clinical trials. Variability in ingredient quality, dosage, and formulation makes it difficult to validate efficacy consistently. Regulatory authorities are increasingly scrutinizing health claims, leading to compliance challenges for manufacturers. Consumer skepticism toward exaggerated marketing claims is also limiting trust. Smaller brands struggle to invest in extensive research and validation processes. These factors collectively slow product adoption and restrict long-term credibility in the immunity-boosting segment.
Rising demand for personalized nutrition and targeted immune-support
Consumers are increasingly seeking targeted immune solutions based on age, lifestyle, dietary preferences, and specific health conditions. Advances in nutrigenomics and microbiome research are enabling customized formulations. Digital health platforms and mobile applications are facilitating personalized supplement recommendations. Brands are leveraging data analytics and AI-driven tools to enhance consumer engagement and product relevance. Subscription-based personalized nutrition models are gaining traction, especially among urban consumers. This shift toward tailored immune-support solutions is creating new growth avenues for innovation-driven companies.
Intense competition from established brands
Large players benefit from strong brand recognition, extensive distribution networks, and significant marketing budgets. New entrants face difficulties in differentiating products in a crowded marketplace. Price competition and frequent product launches increase pressure on margins. Established brands often dominate shelf space in both offline and online retail channels. Private-label products from retailers are further intensifying competitive dynamics.
Covid-19 Impact
The COVID-19 pandemic significantly reshaped the immunity-boosting foods, beverages, and supplements market. Heightened awareness about immune health led to a sharp surge in demand for vitamins, herbal supplements, and functional beverages. Supply chain disruptions initially affected raw material sourcing and production capacities. However, the pandemic accelerated digital sales channels and direct-to-consumer models. Regulatory authorities temporarily eased norms to ensure product availability during peak demand. Post-pandemic, immunity products have transitioned from short-term preventive use to daily wellness essentials.
The supplements segment is expected to be the largest during the forecast period
The supplements segment is expected to account for the largest market share during the forecast period, due to its convenience, concentrated nutrition, and wide availability. Capsules, tablets, powders, and gummies offer easy consumption and precise dosage control. High consumer awareness of vitamins, minerals, probiotics, and herbal extracts supports strong demand. Supplements are widely used across age groups for preventive and therapeutic immune support. Frequent product innovations and clean-label formulations are enhancing segment attractiveness. Strong presence across pharmacies, supermarkets, and online platforms boosts accessibility.
The online retail segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the online retail segment is predicted to witness the highest growth rate, due to increasing digital adoption and convenience. E-commerce platforms offer a wide range of immunity products with transparent ingredient information and customer reviews. Subscription models and personalized recommendations are enhancing customer retention. Competitive pricing and doorstep delivery are attracting urban and tech-savvy consumers. The rise of health-focused online marketplaces is expanding product reach. Brands are leveraging social media and influencer marketing to drive online sales.
During the forecast period, the North America region is expected to hold the largest market share, due to high health awareness and strong purchasing power. Consumers actively invest in preventive healthcare and dietary supplements. The region has a well-established nutraceutical industry supported by robust R&D capabilities. Favorable regulatory frameworks enable faster commercialization of immunity products. High prevalence of lifestyle diseases further fuels demand. Strong presence of leading global brands enhances market penetration.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, owing to rapid urbanization and rising disposable incomes. Growing middle-class populations are increasingly prioritizing health and wellness. Traditional medicine systems such as Ayurveda and Traditional Chinese Medicine are influencing immunity-focused consumption. Increasing awareness of preventive healthcare post-pandemic is accelerating demand. Expansion of e-commerce platforms is improving product accessibility across the region. Governments are promoting nutrition and wellness initiatives to improve public health.
Key players in the market
Some of the key players profiled in the Immunity-Boosting Foods, Beverages & Supplements Market include Nestle S.A., Glanbia plc, Danone S.A., Nature's Way, Unilever PLC, Yakult Honsha, PepsiCo Inc., NOW Foods, The Coca-Cola Company, GNC Holdings Inc., Amway Corp., Abbott Laboratories, Herbalife, Pfizer Inc., and Bayer AG.
In November 2025, Nestle has been chosen to join the Frontier Firm AI Initiative, a multi-year collaboration launched by the Digital Data Design Institute at Harvard (D^3) and Microsoft. The initiative brings together forward-focused organizations and academic minds to explore and shape the future of human-led, AI-driven business.
In November 2025, Abbott and Exact Sciences announced a definitive agreement for Abbott to acquire Exact Sciences, which will enable it to enter and lead in fast-growing cancer diagnostics segments, serving millions more people. Under the terms of the agreement, Exact Sciences shareholders will receive $105 per common share, representing a total equity value of approximately $21 billion.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.